2BH Stock Chart & Stats
€344.40
€4.80(1.41%)
At close: 4:00 PM EDT
€344.40
€4.80(1.41%)
Day’s Range― - ―
52-Week Range€305.50 - €474.50
Previous CloseN/A
Volume0.00
Average Volume (3M)35.00
Market Cap
€75.55B
Enterprise Value€140.73K
Total Cash (Recent Filing)€1.01B
Total Debt (Recent Filing)€48.78B
Price to Earnings (P/E)13.4
Beta0.30
Next Earnings
Oct 23, 2026EPS Estimate
5.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)29.96
Shares Outstanding216,501,500
10 Day Avg. Volume16
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)-17.87
Price to Sales (P/S)1.42
P/FCF Ratio14.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€395.83Price Target Upside14.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)25.63
Revenue Forecast (FY)€68.05B
Bulls Say, Bears Say
Bulls Say
Scale & ProfitabilityHCA’s large scale and sustained operating margins produce durable operating cash flow across cycles. A broad acute and outpatient footprint enables efficient fixed-cost absorption, negotiating leverage with payers, and the ability to fund investments and shareholder returns over the medium term.
Strong Cash GenerationMaterial operating and free cash flow provides structural financial flexibility to fund capital expansion, service interest, repurchase stock and pay dividends. Even with some softening, this level of cash conversion supports ongoing investment and incremental deleveraging over the next several quarters.
Network & Outpatient ExpansionOngoing site growth and a large outpatient pipeline align with secular shifts toward ambulatory care, expanding access and capturing lower-cost volumes. The multi-year CapEx program supports capacity and market share gains, enhancing durable revenue diversification and margin mix improvement.
Bears Say
Elevated LeverageVery high gross debt and negative equity materially limit financial flexibility. Elevated leverage increases refinancing, covenant and interest-rate sensitivity, constraining the company’s ability to absorb macro shocks or pursue large strategic initiatives without prioritizing liability management.
Policy-driven Payer-mix HeadwindA near-term structural shift of exchange members to uninsured reduces reimbursement and raises uncompensated care. Because this is driven by policy/affordability changes and concentrated in certain divisions, it is a persistent revenue and margin headwind that can depress EBITDA and cash flow for multiple quarters.
Margin & Cash-flow PressureProgressive margin compression and weakening free cash flow reduce the firm’s buffer to absorb shocks and to delever. Elevated professional fees and softer elective-surgery volumes are structural mix and cost pressures that can persist, limiting sustainable margin recovery absent decisive cost or revenue actions.
HCA Healthcare News
2BH FAQ
What was Hca Healthcare’s price range in the past 12 months?
Hca Healthcare lowest stock price was €305.50 and its highest was €474.50 in the past 12 months.
What is Hca Healthcare’s market cap?
Hca Healthcare’s market cap is €75.55B.
When is Hca Healthcare’s upcoming earnings report date?
Hca Healthcare’s upcoming earnings report date is Oct 23, 2026 which is in 82 days.
How were Hca Healthcare’s earnings last quarter?
Hca Healthcare released its earnings results on Jul 24, 2026. The company reported €6.594 earnings per share for the quarter, beating the consensus estimate of €6.569 by €0.024.
Is Hca Healthcare overvalued?
According to Wall Street analysts Hca Healthcare’s price is currently Undervalued.
Does Hca Healthcare pay dividends?
Hca Healthcare does not currently pay dividends.
What is Hca Healthcare’s EPS estimate?
Hca Healthcare’s EPS estimate is 5.89.
How many shares outstanding does Hca Healthcare have?
Hca Healthcare has 216,501,500 shares outstanding.
What happened to Hca Healthcare’s price movement after its last earnings report?
Hca Healthcare reported an EPS of €6.594 in its last earnings report, beating expectations of €6.569. Following the earnings report the stock price went up 2.847%.
Which hedge fund is a major shareholder of Hca Healthcare?
Currently, no hedge funds are holding shares in DE:2BH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HCA Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€395.83 (14.93% Upside)
€395.83 (14.93% Upside)
Blogger Sentiment
Bullish
DE:2BH Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Bullish
Bullish news 60%
Bearish news 40%
Bearish news 40%
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.33%
12-Months-Change
Fundamentals
Return on Equity
0.75%
Trailing 12-Months
Asset Growth
6.24%
Trailing 12-Months
Company Description
Hca Healthcare
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
2BH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: operational demand and underlying profitability showed resilience (11% EPS growth, volume increases outside the exchanges, meaningful Medicaid supplemental payments, ongoing capital deployment and share repurchases). However, a large, concentrated payer-mix shock from the expiration of enhanced premium tax credits (exchange enrollment down ~15% and near 1-for-1 migration to uninsured) created a significant adjusted EBITDA headwind (~$400M in Q2 and an estimated $1.0B–$1.2B full-year impact), contributed to lower cash flow this quarter, and pressured elective surgical volumes. Management has responded by updating guidance (now aligned with long-term adjusted EBITDA growth of 4%–6%), advancing cost resiliency programs, and preserving capital allocation priorities. Overall, positives (profitability, cost discipline, supplemental payment benefits, and network expansion) are balanced against material policy-driven revenue and payer-mix challenges.View all DE:2BH earnings summaries2BH Revenue Breakdown
28.15% National Group
32.68% Atlantic Group
34.98% American Group
4.19% Corporate and other

2BH Stock 12 Month Forecast
Average Price Target
€395.83
▲(14.93% Upside)
Technical Analysis
Community Health
―
Encompass Health
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―










